azacitidine and Leukemia L 1210

azacitidine has been researched along with Leukemia L 1210 in 65 studies

Research

Studies (65)

Timeframe	Studies, this research(%)	All Research%
pre-1990	57 (87.69)	18.7374
1990's	4 (6.15)	18.2507
2000's	3 (4.62)	29.6817
2010's	1 (1.54)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abbasi, MM; Beisler, JA; Driscoll, JS; Kelley, JA	1
Beisler, JA	1
Abbasi, MM; Beisler, JA; Driscoll, JS	3
Hansch, C; Khwaja, TA; Selassie, CD	1
Cook, PD; McNamara, DJ	1
Charbonneau, M; Momparler, LF; Momparler, RL; Raynal, NJ	1
Momparler, LF; Momparler, RL; Raynal, NJ; Rivard, GE	1
Bernstein, ML; Lemaire, M; Marquez, VE; Momparler, LF; Momparler, RL	1
Huang, TH; Liu, JC; Plass, C; Potter, D; Smith, LT; Wang, SH; Wu, J; Wu, YZ	1
Momparler, LF; Momparler, RL; Samson, J	2
Covey, JM; Zaharko, DS	4
Lee, MH; Sartorelli, AC	1
Abbasi, MM; Beisler, JA; Glazer, RI; Peale, AL	1
Glazer, RI; Hartman, KD	1
Cihák, A; Veselý, J	3
Cadman, E; Grant, S; Jakubowski, A; Rauscher, F	1
Darzynkiewicz, Z; Melamed, MR; Staiano-Coico, L; Traganos, F	1
Coulter, D; Presant, CA; Valeriote, F; Vietti, TJ	1
Coulter, DM; Presant, CA; Valeriote, F; Vietti, TJ	1
Cadman, E; Grant, S; Margolin, J; Rauscher, F	1
Veselý, J	2
Jones, PA; Momparler, RL; Wilson, VL	1
Campbell, J; Li, ZR; Rustum, YM	1
Blowers, CL; Buskirk, HH; Hanka, LJ; Li, LH; Neil, GL	1
Pískala, A; Veselý, J	2
Lu, LJ; Randerath, K	1
Glazier, RI; Minford, J; Nichols, M; Shackney, S; Zwelling, LA	1
Chabot, GG; Momparler, RL	2
Jacquemin-Sablon, A; Segal-Bendirdjian, E	2
Fabianowska-Majewska, K; Wyczechowska, D	1
Presant, CA; Valeriote, F; Vietti, T	1
Berger, AE; Bhuyan, BK; DeSante, DC; Neil, GL	1
Muggia, FM; Slavik, M; Von Hoff, DD	1
Carter, SK; Slavik, M	1
Presant, CA; Valeriote, F; Vietti, TJ	1
Abbasi, MM; Beisler, JA; Voytek, P; Wolpert-DeFilippes, MK	1
Gonzales, FA; Momparier, RL	1
Gaudio, L; Kelly, CJ; Schoenemann, PT; Wodinsky, I; Yesair, DW	1
Covey, JM; D'Incalci, M; Kohn, KW; Zaharko, DS	1
Zaharko, DS	1
Driscoll, JS; Johns, DG; Plowman, J	1
Covey, JM; D'Incalci, M; Kohn, KW; Tilchen, EJ; Zaharko, DS	1
Colombo, T; D'Incalci, M; Rossi, C	1
Allegrucci, M; Borri Voltattorni, C; Dominici, P; Fioretti, MC; Puccetti, P; Romani, L	1
Avramis, VI; Powell, WC	1
Fioretti, MC; Fuschiotti, P; Puccetti, P; Romani, L	1
Momparler, LF; Momparler, RL	1
Covey, JM; Muneses, CC; Zaharko, DS	1
Oliverio, VT	1
Carter, SK	1
Heby, O; Russell, DH	1
Gang, M; Kline, I; Sirica, AE; Venditti, JM; Woodman, RJ	1
Dulmadge, EA; Lloyd, HH; Wilkoff, LJ	1

Reviews

5 review(s) available for azacitidine and Leukemia L 1210

Article	Year
[Cisplatin resistance in a murine leukemia cell line associated with defect of apoptosis]. Bulletin du cancer, 1996, Volume: 83, Issue:5 Topics: Alkaloids; Animals; Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Cell Division; Cisplatin; Clone Cells; DNA, Neoplasm; Drug Resistance, Neoplasm; Endonucleases; Leukemia L1210; Mice; Protein Kinase C; Staurosporine; Tumor Cells, Cultured	1996
5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia. Annals of internal medicine, 1976, Volume: 85, Issue:2 Topics: Animals; Azacitidine; Breast Neoplasms; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemistry; Europe; Female; Humans; Kinetics; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukopenia; Liver; Nausea; Neoplasms, Experimental; Neuromuscular Diseases; RNA, Messenger; United States; Vomiting	1976
Investigational drugs under study by the United States National Cancer Institute. Cancer treatment reviews, 1976, Volume: 3, Issue:1 Topics: Acrylates; Alkylating Agents; Ancitabine; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Chemical Phenomena; Chemistry; Chromomycins; Cisplatin; DNA, Neoplasm; Drug Evaluation, Preclinical; Etoposide; Humans; Ifosfamide; Leukemia L1210; Mice; Mitosis; National Institutes of Health (U.S.); Neoplasms; Neoplasms, Experimental; Razoxane; Tegafur; Teniposide; United States	1976
[Possibilities for the clinical use of 5-azacytidine]. Voprosy onkologii, 1977, Volume: 23, Issue:10 Topics: Adult; Animals; Azacitidine; Biopharmaceutics; Chemical Phenomena; Chemistry; Child; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Mice, Inbred AKR; Molecular Conformation	1977
Current status of new agents. Cancer chemotherapy reports. Part 3, 1972, Volume: 3, Issue:1 Topics: Alopecia; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Azacitidine; Azaguanine; Carmustine; Cyclohexanes; Drug Combinations; Heart; Humans; Leukemia L1210; Nitrosourea Compounds; Platinum; Prednisone; Remission, Spontaneous	1972

Trials

1 trial(s) available for azacitidine and Leukemia L 1210

Article	Year
[Possibilities for the clinical use of 5-azacytidine]. Voprosy onkologii, 1977, Volume: 23, Issue:10 Topics: Adult; Animals; Azacitidine; Biopharmaceutics; Chemical Phenomena; Chemistry; Child; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Mice, Inbred AKR; Molecular Conformation	1977

Article

Year

[Possibilities for the clinical use of 5-azacytidine].

Voprosy onkologii, 1977, Volume: 23, Issue:10

Topics: Adult; Animals; Azacitidine; Biopharmaceutics; Chemical Phenomena; Chemistry; Child; Clinical Trials as Topic; Drug Evaluation; Drug Evaluation, Preclinical; Humans; In Vitro Techniques; Leukemia L1210; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Mice; Mice, Inbred AKR; Molecular Conformation

1977

Other Studies

60 other study(ies) available for azacitidine and Leukemia L 1210

Article	Year
Synthesis and antitumor activity of dihydro-5-azacytidine, a hydrolytically stable analogue of 5-azacytidine. Journal of medicinal chemistry, 1977, Volume: 20, Issue:6 Topics: Animals; Antineoplastic Agents; Azacitidine; Hydrolysis; Leukemia L1210; Leukemia, Experimental; Melanoma; Mice; Neoplasms, Experimental	1977
Isolation, characterization, and properties of a labile hydrolysis product of the antitumor nucleoside, 5-azacytidine. Journal of medicinal chemistry, 1978, Volume: 21, Issue:2 Topics: Animals; Azacitidine; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Stability; Hydrolysis; Leukemia L1210; Mice; Solutions; Time Factors	1978
Synthesis and antitumor activity of 5-azacytosine arabinoside. Journal of medicinal chemistry, 1979, Volume: 22, Issue:10 Topics: Animals; Antineoplastic Agents; Azacitidine; Chemical Phenomena; Chemistry; Leukemia L1210; Mice; Stereoisomerism	1979
Structure-activity relationships of antineoplastic agents in multidrug resistance. Journal of medicinal chemistry, 1990, Volume: 33, Issue:7 Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured	1990
Synthesis and antitumor activity of fluorine-substituted 4-amino-2(1H)-pyridinones and their nucleosides. 3-Deazacytosines. Journal of medicinal chemistry, 1987, Volume: 30, Issue:2 Topics: Animals; Antimetabolites, Antineoplastic; Cytosine; Drug Evaluation, Preclinical; Indicators and Reagents; Leukemia L1210; Magnetic Resonance Spectroscopy; Mass Spectrometry; Mice; Spectrophotometry; Structure-Activity Relationship	1987
Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia. Oncology research, 2008, Volume: 17, Issue:5 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cyclin-Dependent Kinase Inhibitor p57; Decitabine; DNA Methylation; DNA, Neoplasm; Drug Synergism; Genistein; HL-60 Cells; Humans; Leukemia; Leukemia L1210; Male; Mice; Promoter Regions, Genetic	2008
3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase. Leukemia research, 2011, Volume: 35, Issue:1 Topics: 3-Deazauridine; Animals; Azacitidine; Cell Line, Tumor; Decitabine; Deoxycytidine Kinase; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia L1210; Male; Mice; Reverse Transcriptase Polymerase Chain Reaction	2011
Enhancement of antineoplastic action of 5-aza-2'-deoxycytidine by zebularine on L1210 leukemia. Anti-cancer drugs, 2005, Volume: 16, Issue:3 Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Cytidine; Cytidine Deaminase; Decitabine; DNA Methylation; Dose-Response Relationship, Drug; Drug Interactions; Humans; Leukemia L1210; Male; Mice; Pyrimidine Nucleosides; Reverse Transcriptase Polymerase Chain Reaction; Tumor Stem Cell Assay	2005
Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing. BMC genomics, 2007, May-24, Volume: 8 Topics: Acetylation; Animals; Azacitidine; Cell Line, Tumor; Chromatin Immunoprecipitation; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Gene Expression Regulation; Gene Silencing; Histones; Hydroxamic Acids; Leukemia L1210; Lysine; Methylation; Mice; Mice, Inbred DBA; Oligonucleotide Array Sequence Analysis; Protein Processing, Post-Translational	2007
Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia. Leukemia research, 1984, Volume: 8, Issue:6 Topics: Animals; Antineoplastic Agents; Azacitidine; Cytarabine; Decitabine; DNA, Neoplasm; Leukemia L1210; Male; Methylation; Mice; Mice, Inbred BALB C; Mice, Inbred DBA	1984
Effects of 5-aza-2'-deoxycytidine in combination with the biochemical modulator thymidine or the immune modulator pyran copolymer on L1210 leukemia-bearing mice. Cancer treatment reports, 1984, Volume: 68, Issue:10 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Body Weight; Decitabine; Leukemia L1210; Male; Mice; Polymers; Pyran Copolymer; Thymidine; Time Factors	1984
Combination chemotherapy with Clostridium perfringens phospholipase C and cytosine antimetabolites: complementary inhibition directed at membrane lipids. Cancer drug delivery, 1983, Volume: 1, Issue:1 Topics: Animals; Azacitidine; Cell Line; Choline; Clostridium; Cytarabine; Leukemia L1210; Membrane Lipids; Mice; Microscopy, Electron, Scanning; Sarcoma 180; Type C Phospholipases	1983
The effect of 5-azacytidine and dihydro-5-azacytidine on nuclear ribosomal RNA and poly(A) RNA synthesis in L1210 cells in vitro. Molecular pharmacology, 1980, Volume: 17, Issue:1 Topics: Adenosine; Animals; Azacitidine; Cells, Cultured; Depression, Chemical; Dose-Response Relationship, Drug; Leukemia L1210; Methionine; Methylation; Mice; Poly A; RNA; RNA, Heterogeneous Nuclear; RNA, Messenger; RNA, Ribosomal; Uridine	1980
The comparative effects of 5-azacytidine and dihydro-5-azacytidine on 4 S and 5 S nuclear RNA. Molecular pharmacology, 1980, Volume: 17, Issue:2 Topics: Animals; Azacitidine; Chromatography, Thin Layer; Electrophoresis, Polyacrylamide Gel; Leukemia L1210; Methylation; Mice; Molecular Weight; RNA, Neoplasm	1980
Kinetics of 5-aza-2'-deoxycytidine phosphorylation in mouse spleen and L1210 leukemic cell extracts. Neoplasma, 1980, Volume: 27, Issue:2 Topics: Animals; Azacitidine; Binding, Competitive; Cell-Free System; Decitabine; Deoxycytidine Kinase; Deoxyribonucleosides; Kinetics; Leukemia L1210; Mice; Nucleosides; Phosphorylation; Spleen	1980
Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells. Cancer research, 1981, Volume: 41, Issue:2 Topics: Animals; Aspartate Carbamoyltransferase; Aspartic Acid; Azacitidine; Cell Division; Cytidine; DNA, Neoplasm; Leukemia L1210; Leukemia, Experimental; Mice; Neoplasm Proteins; Organophosphorus Compounds; Phosphonoacetic Acid; RNA, Neoplasm; Uridine	1981
Effects of dihydro-5-azacytidine on cell survival and cell cycle progression of cultured mammalian cells. Cancer research, 1981, Volume: 41, Issue:3 Topics: Animals; Azacitidine; Cell Cycle; Cell Survival; Cells, Cultured; Cricetinae; Cricetulus; Female; Humans; Leukemia L1210; Leukemia, Experimental; Lymphocyte Activation; Mice; Ovary; Phytohemagglutinins; RNA	1981
Contrasting cytotoxicity kinetics of 5-azacytidine and dihydro-5-azacytidine hydrochloride in L1210 leukemia in mice. Journal of the National Cancer Institute, 1981, Volume: 66, Issue:6 Topics: Animals; Azacitidine; Bone Marrow; Cell Survival; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Kinetics; Lethal Dose 50; Leukemia L1210; Male; Mice; Spleen	1981
Chemotherapy of L1210 leukemia with 5-azacytidine in combination with vincristine, adriamycin, or beta-cytosine arabinoside. Journal of the National Cancer Institute, 1981, Volume: 67, Issue:6 Topics: Animals; Azacitidine; Colony-Forming Units Assay; Cytarabine; Doxorubicin; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Vincristine	1981
Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line. Cancer research, 1982, Volume: 42, Issue:2 Topics: Animals; Antineoplastic Agents; Azacitidine; Biological Transport; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Decitabine; DNA; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Humans; Leukemia L1210; Leukemia, Myeloid, Acute; Mice; Thymidine; Time Factors	1982
Synergistic effect of cis-dichlorodiammineplatinum and 5-aza-2'-deoxycytidine on mouse leukemic cells in vivo and in vitro. International journal of cancer, 1982, Jan-15, Volume: 29, Issue:1 Topics: Animals; Azacitidine; Cell Division; Cisplatin; Decitabine; DNA, Neoplasm; Drug Synergism; In Vitro Techniques; Leucine; Leukemia L1210; Leukemia, Experimental; Male; Mice; Mice, Inbred Strains; RNA, Neoplasm	1982
Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine. International journal of cancer, 1982, Sep-15, Volume: 30, Issue:3 Topics: Animals; Antineoplastic Agents; Azacitidine; Decitabine; Deoxyguanosine; Drug Evaluation; Drug Therapy, Combination; Leukemia L1210; Male; Mice; Thionucleosides	1982
Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action. Cancer research, 1983, Volume: 43, Issue:8 Topics: 5-Methylcytosine; Animals; Antineoplastic Agents; Azacitidine; Cytosine; Decitabine; DNA; DNA (Cytosine-5-)-Methyltransferases; Dose-Response Relationship, Drug; Leukemia L1210; Male; Methylation; Mice	1983
Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine. Cancer treatment reports, 1983, Volume: 67, Issue:6 Topics: 3-Deazauridine; Animals; Azacitidine; Chromatography, High Pressure Liquid; Cytarabine; Drug Therapy, Combination; Lethal Dose 50; Leukemia L1210; Mice; Mice, Inbred DBA; Purine Nucleotides; Pyrimidine Nucleotides; Uridine	1983
Biological evaluation of stability of 5-azacytidine. The Journal of antibiotics, 1984, Volume: 37, Issue:4 Topics: Animals; Azacitidine; Drug Stability; Escherichia coli; Leukemia L1210; Mice; Temperature	1984
Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo. Cancer research, 1984, Volume: 44, Issue:11 Topics: Animals; Azacitidine; Cell Division; Decitabine; Deoxycytidine Kinase; DNA Replication; Drug Evaluation, Preclinical; Isomerism; Leukemia L1210; Mice; Transcription, Genetic	1984
Long term instability and molecular mechanism of 5-azacytidine-induced DNA hypomethylation in normal and neoplastic tissues in vivo. Molecular pharmacology, 1984, Volume: 26, Issue:3 Topics: Animals; Azacitidine; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA, Neoplasm; Kinetics; Leukemia L1210; Liver; Liver Regeneration; Male; Methylation; Methyltransferases; Mice; Mice, Inbred BALB C; Mice, Inbred DBA	1984
Enhancement of intercalator-induced deoxyribonucleic acid scission and cytotoxicity in murine leukemia cells treated with 5-azacytidine. Biochemical pharmacology, 1984, Dec-01, Volume: 33, Issue:23 Topics: Animals; Azacitidine; Cell Survival; DNA Replication; DNA, Neoplasm; Intercalating Agents; Leukemia L1210; Mice	1984
Effects of dose and duration of exposure on 5-aza-2'-deoxycytidine cytotoxicity for L1210 leukemia in vitro. Cancer treatment reports, 1984, Volume: 68, Issue:12 Topics: Animals; Azacitidine; Cell Division; Cell Survival; Clone Cells; Decitabine; Kinetics; Leukemia L1210; Mice; Time Factors	1984
Antileukemic activity of 5-aza-2'-deoxycytidine and cytarabine against intracerebral L1210 murine leukemia. Cancer treatment reports, 1984, Volume: 68, Issue:12 Topics: Animals; Azacitidine; Brain Neoplasms; Cytarabine; Decitabine; Dose-Response Relationship, Drug; Kinetics; Leukemia L1210; Male; Mice; Mice, Inbred Strains	1984
Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process. Experimental cell research, 1995, Volume: 218, Issue:1 Topics: Alkaloids; Animals; Apoptosis; Azacitidine; Cell Division; Cell Nucleus; Cisplatin; Clone Cells; Cycloheximide; DNA, Neoplasm; Drug Resistance; Endonucleases; Leukemia L1210; Mice; Microscopy, Confocal; Microscopy, Electron; Protein Kinase C; Staurosporine; Tumor Cells, Cultured	1995
Does 2-chlorodeoxyadenosine contribute to alteration of DNA methyltransferase activity? Advances in experimental medicine and biology, 1998, Volume: 431 Topics: Adenosylhomocysteinase; Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Cladribine; Decitabine; DNA (Cytosine-5-)-Methyltransferases; Hydrolases; Kinetics; Leukemia L1210; Mice; Tumor Cells, Cultured; Vidarabine	1998
Kinetics of both leukemic and normal cell population reduction following 5-azacytidine. Cancer research, 1975, Volume: 35, Issue:8 Topics: Animals; Azacitidine; Bone Marrow; Bone Marrow Cells; Dose-Response Relationship, Drug; Femur; Hematopoietic Stem Cells; Kinetics; Leukemia L1210; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Time Factors	1975
Combination chemotherapy of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine and 5-azacytidine. Cancer research, 1976, Volume: 36, Issue:3 Topics: Animals; Azacitidine; Body Weight; Cells, Cultured; DNA Replication; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Leukemia L1210; Mice	1976
Biological characterization of a prolonged antileukemic effect of 5-azacytidine. Cancer research, 1977, Volume: 37, Issue:2 Topics: Animals; Azacitidine; Bone Marrow; Bone Marrow Cells; Cell Division; Cell Survival; Cytidine; Dose-Response Relationship, Drug; Immunity; Leukemia L1210; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Thymidine; Time Factors; Transplantation, Isogeneic	1977
Dihydro-5-azacytidine hydrochloride, a biologically active and chemically stable analog of 5-azacytidine. Cancer treatment reports, 1976, Volume: 60, Issue:11 Topics: Animals; Azacitidine; Leukemia L1210; Mice	1976
Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine. Cancer research, 1977, Volume: 37, Issue:7 Pt 1 Topics: Animals; Azacitidine; Cell Division; Cells, Cultured; Cytidine; Cytidine Deaminase; Deoxycytidine; Drug Synergism; Kinetics; Leukemia L1210; Oxidative Phosphorylation; Tetrahydrouridine; Thymidine; Uridine	1977
Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice. Cancer research, 1977, Volume: 37, Issue:10 Topics: Animals; Azacitidine; Deoxycytidine; Epithelium; Female; Leukemia L1210; Leukemia, Experimental; Liver; Lymph Nodes; Mice; Mice, Inbred AKR; Mice, Inbred BALB C; Mice, Inbred DBA; Precancerous Conditions; Thymidine	1977
The synthesis and antitumor activity of arabinosyl-5-azacytosine. Biochemical pharmacology, 1977, Dec-15, Volume: 26, Issue:24 Topics: Animals; Antineoplastic Agents; Azacitidine; Cytarabine; Leukemia L1210; Mice	1977
Effect of intravenous infusion of 5-aza-2'-deoxycytidine on survival time of mice with L1210 leukemia. Cancer research, 1978, Volume: 38, Issue:9 Topics: Animals; Azacitidine; Cell Survival; Deoxycytidine; In Vitro Techniques; Infusions, Parenteral; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Time Factors	1978
Pharmacokinetic considerations in evaluating the effects of tetrahydrouridine on 5-azacytidine chemotherapy in L1210 leukemic mice. Cancer treatment reports, 1978, Volume: 62, Issue:7 Topics: Animals; Azacitidine; Drug Therapy, Combination; Female; Infusions, Parenteral; Injections, Intraperitoneal; Leukemia L1210; Mice; Tetrahydrouridine; Uridine	1978
DNA alkali-labile sites induced by incorporation of 5-aza-2'-deoxycytidine into DNA of mouse leukemia L1210 cells. Cancer research, 1985, Volume: 45, Issue:7 Topics: Alkalies; Animals; Antineoplastic Agents; Azacitidine; Cells, Cultured; Decitabine; DNA, Neoplasm; Hydrogen-Ion Concentration; Leukemia L1210; Mice	1985
Immunological concepts and the combination of cyclophosphamide with 5-aza-2'-deoxycytidine on L1210 in vivo. Journal of immunopharmacology, 1985, Volume: 7, Issue:2 Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Survival; Cyclophosphamide; Decitabine; Drug Synergism; Drug Therapy, Combination; Leukemia L1210; Male; Mice; Mice, Inbred Strains; T-Lymphocytes, Regulatory	1985
Arabinosyl-5-azacytosine: plasma kinetics and therapeutic response (L1210) in vitro and in vivo in mice. Investigational new drugs, 1985, Volume: 3, Issue:4 Topics: Animals; Antineoplastic Agents; Azacitidine; Cells, Cultured; Decitabine; Kinetics; Leukemia L1210; Male; Mice; Mice, Inbred Strains	1985
Comparison of the activity of arabinosyl-5-azacytosine, arabinosyl cytosine, and 5-azacytidine against intracerebrally implanted L1210 leukemia. Investigational new drugs, 1985, Volume: 3, Issue:4 Topics: Animals; Antineoplastic Agents; Azacitidine; Brain Neoplasms; Carmustine; Cytarabine; Leukemia L1210; Mice; Mice, Inbred Strains; Neoplasm Transplantation	1985
Mechanism of action of 1-beta-D-arabinofuranosyl-5-azacytosine and its effects in L1210 mouse leukemia cells. Neoplasma, 1986, Volume: 33, Issue:1 Topics: Animals; Antineoplastic Agents; Azacitidine; Bone Marrow; Bone Marrow Cells; Cell Division; Cell Line; Cell Survival; Cytarabine; Decitabine; Drug Evaluation, Preclinical; Kinetics; Leukemia L1210; Leukocyte Count; Male; Mice; Mice, Inbred DBA; Nucleosides; Phosphorylation; Thymidine	1986
Effects of 5-aza-2'-deoxycytidine on survival and cell cycle progression of L1210 leukemia cells. Leukemia research, 1986, Volume: 10, Issue:5 Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Cycle; Cell Survival; Cells, Cultured; Decitabine; DNA, Neoplasm; Leukemia L1210; Mice; Thymidine	1986
Differences in DNA damage produced by incorporation of 5-aza-2'-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells. Cancer research, 1986, Volume: 46, Issue:11 Topics: Animals; Azacitidine; Cell Cycle; Cell Line; Decitabine; DNA; DNA Damage; DNA Replication; Humans; Hydrogen-Ion Concentration; Leukemia L1210; Lymphocytes; Mice	1986
Antagonism of 5-aza-2'-deoxycytidine antileukemic activity by concomitant treatment with cytarabine. Cancer treatment reports, 1986, Volume: 70, Issue:12 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cytarabine; Decitabine; Drug Interactions; Leukemia L1210; Male; Mice; Statistics as Topic	1986
DNA methylating activity in murine lymphoma cells treated with xenogenizing chemicals. Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc, 1987, Volume: 1 Topics: Animals; Azacitidine; Carmustine; DNA, Neoplasm; Leukemia L1210; Male; Methylation; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Triazenes	1987
High degree of resistance to 5-aza-2'-deoxycytidine in L1210 cells in vitro associated with almost complete loss of deoxycytidine kinase activity. Neoplasma, 1987, Volume: 34, Issue:6 Topics: 5-Methylcytosine; Animals; Azacitidine; Cell Line; Cells, Cultured; Cytosine; Decitabine; Deoxycytidine; Deoxycytidine Kinase; DNA (Cytosine-5-)-Methyltransferases; Drug Resistance; Leukemia L1210; Mice; Phosphorylation; Phosphotransferases	1987
Biochemical pharmacology of 5,6-dihydro-5-azacytidine (DHAC) and DNA hypomethylation in tumor (L1210)-bearing mice. Cancer chemotherapy and pharmacology, 1988, Volume: 21, Issue:2 Topics: Animals; Azacitidine; Bone Marrow; Brain; Chromatography, High Pressure Liquid; DNA, Neoplasm; Erythrocytes; Intestinal Mucosa; Kidney; Leukemia L1210; Liver; Lung; Male; Methylation; Mice; Muscles; Myocardium; Spleen; Testis; Tissue Distribution; Tumor Cells, Cultured	1988
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens. Cancer immunology, immunotherapy : CII, 1989, Volume: 29, Issue:2 Topics: 5-Methylcytosine; Animals; Antigens, Neoplasm; Azacitidine; Clone Cells; Cytosine; DNA, Neoplasm; Female; Leukemia L1210; Male; Methylation; Methylnitronitrosoguanidine; Mice; Mutagens; Phenotype; Triazenes	1989
Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine. Cancer chemotherapy and pharmacology, 1989, Volume: 25, Issue:1 Topics: 3-Deazauridine; Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Line; Cytarabine; Decitabine; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Tumor Cells, Cultured	1989
Comparison of the in vitro cytotoxicity (L1210) of 5-aza-2'-deoxycytidine with its therapeutic and toxic effects in mice. European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:1 Topics: Animals; Antineoplastic Agents; Azacitidine; Cell Survival; Cells, Cultured; Decitabine; Dose-Response Relationship, Drug; Kinetics; Leukemia L1210; Mice	1985
Experimental chemotherapy (L1210) with 5-aza-2'-deoxycytidine in combination with pyran copolymer (MVE-4), an immune adjuvant. Journal of the National Cancer Institute, 1985, Volume: 74, Issue:6 Topics: Adjuvants, Immunologic; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Decitabine; Leukemia L1210; Mice; Mice, Inbred Strains; Pyran Copolymer	1985
Second Joint Working Conference: National Cancer Institute Chemotherapy Program. Working session report: pharmacology. Cancer chemotherapy reports. Part 3, 1972, Volume: 3, Issue:1 Topics: Alkaloids; Animals; Antimetabolites; Antineoplastic Agents; Autoradiography; Azacitidine; Carbazoles; Carbon Isotopes; Cell Line; Cells, Cultured; Cricetinae; Cytarabine; DNA; DNA Nucleotidyltransferases; Dogs; Half-Life; Humans; Leukemia L1210; Lung; Pyridines; RNA	1972
Depression of polyamine synthesis in L1210 leukemic mice during treatment with a potent antileukemic agent, 5-azacytidine. Cancer research, 1973, Volume: 33, Issue:1 Topics: Animals; Antineoplastic Agents; Azacitidine; Carboxy-Lyases; Cytidine; Depression, Chemical; Enzyme Repression; Injections, Intraperitoneal; Leukemia L1210; Liver; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Organ Size; Ornithine; Polyamines; Putrescine; S-Adenosylmethionine; Spermidine; Spleen; Triazines	1973
The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents. Chemotherapy, 1973, Volume: 18, Issue:3 Topics: Amines; Animals; Antineoplastic Agents; Azacitidine; Camptothecin; Carmustine; Chlorides; Cyclophosphamide; Cytarabine; Drug Synergism; Emetine; Fluorouracil; Ketones; Leukemia L1210; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Piperazines; Platinum; Propane; Time Factors	1973
Kinetics of the reduction in viability of cultured L1210 leukemia cells exposed to 5-azacytidine (NSC-102816). Cancer chemotherapy reports, 1972, Volume: 56, Issue:5 Topics: Animals; Azacitidine; Cell Division; Cell Survival; Cells, Cultured; Chromatography, Paper; Cytidine; Hydrolysis; Kinetics; Leukemia L1210; Mice; Time Factors; Triazines	1972